Note that some links may require subscriptions.
A new risk calculator uses 6.6 million spots in an individual's DNA to evaluate risk of Afib, breast cancer, inflammatory bowel disease, heart disease, and diabetes. (New York Times)
Westby Fisher, MD, has raised $118,000 so far in a Gofundme campaign to bankroll a legal war against the American Board of Internal Medicine.
A report warns of the rise in mosquito-borne illness transmission in the U.S. -- with Reno, Nevada, having the biggest change in the number of "disease danger days" since 1970. (CBS News)
The FDA granted breakthrough designation to Novartis and Roche's Xolair, best known for treating asthma, as a treatment for food allergies. (FiercePharma)
Former Cleveland Clinic CEO says the opioid epidemic has "peaked." (CNBC)
Nearly 1 in 5 hospital inpatient bills for enrollees in large-employer health plans include a claim from an out-of-network provider, according to an analysis from the Kaiser Family Foundation.
Why are med students cutting class, and what do medical schools hope to do about it? (STAT News)
A lawyer explains to Retraction Watch how researchers may be liable for "research misconduct" if they "fail to detect false data from another scientist."
Newly acquired Cleveland Indians outfielder Leonys Martin is fighting what has been characterized as a "life-threatening bacterial infection that has affected multiple organs." (NBC Sports)
Ob/gyns push back against the FDA's new regulations on vaginal rejuvenation products, claiming it "may limit availability of innovative therapies" for patients who need them. (NPR)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.